Natixis Incyte Corp Transaction History

Natixis

$16 Billion
Q4 2024

A detailed history of Natixis transactions in Incyte Corp stock. As of the latest transaction made, Natixis holds 114,175 shares of INCY stock, worth $8.23 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

114,175

Holding current value

$8.23 Million

% of portfolio

0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$65.08 - $83.38 $7.43 Million - $9.52 Million	114,175 New	114,175 $7.89 Million
Q1 2024 May 13, 2024	SELL	$56.55 - $66.59 $5.66 Million - $6.67 Million	-100,116 Reduced 85.06%	17,581 $1 Million
Q4 2023 Feb 13, 2024	BUY	$52.16 - $64.19 $5.47 Million - $6.73 Million	104,813 Added 813.51%	117,697 $7.39 Million
Q3 2023 Nov 14, 2023	BUY	$57.77 - $65.93 $20,623 - $23,537	357 Added 2.85%	12,884 $744,000
Q2 2023 Aug 11, 2023	SELL	$60.95 - $75.51 $7.29 Million - $9.03 Million	-119,561 Reduced 90.52%	12,527 $779,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $8.1 Million - $9.92 Million	115,393 Added 691.18%	132,088 $9.55 Million
Q4 2022 Feb 24, 2023	SELL	$67.18 - $84.11 $329,517 - $412,559	-4,905 Reduced 22.71%	16,695 $1.34 Million
Q4 2022 Feb 13, 2023	SELL	$67.18 - $84.11 $9.1 Million - $11.4 Million	-135,387 Reduced 86.24%	21,600 $1.73 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $9.83 Million - $12.3 Million	148,505 Added 1750.83%	156,987 $10.5 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $7.2 Million - $9.05 Million	-108,800 Reduced 92.77%	8,482 $644,000
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $2.24 Million - $2.7 Million	-33,854 Reduced 22.4%	117,282 $9.32 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $1.57 Million - $1.84 Million	-24,826 Reduced 14.11%	151,136 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $9.91 Million - $12.1 Million	144,348 Added 456.6%	175,962 $12.1 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $2.53 Million - $2.77 Million	31,614 New	31,614 $2.66 Million
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $2.02 Million - $2.6 Million	-23,727 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $318,232 - $467,309	4,290 Added 22.07%	23,727 $2.47 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $10.5 Million - $14.2 Million	-165,588 Reduced 89.49%	19,437 $1.42 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $11.9 Million - $15.6 Million	163,458 Added 757.91%	185,025 $16.3 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $1.95 Million - $2.32 Million	-26,773 Reduced 55.38%	21,567 $1.6 Million
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $3.55 Million - $4.29 Million	48,340 New	48,340 $4.11 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $4.16 Million - $4.98 Million	-71,147 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $1.53 Million - $1.84 Million	24,728 Added 53.27%	71,147 $4.92 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $2.82 Million - $3.9 Million	46,419 New	46,419 $3.11 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $637,900 - $775,526	-7,680 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $718,540 - $895,488	7,680 New	7,680 $727,000
Q3 2017 Nov 14, 2017	SELL	$109.15 - $138.27 $7.84 Million - $9.93 Million	-71,804 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	71,804	71,804 $9.04 Million

Others Institutions Holding INCY

# of Institutions

706

Shares Held

189M

Call Options Held

909K

Put Options Held

489K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account